HCPLive Network

Medicare Beneficiaries Use More Brand-Name Drugs Than Veterans Affairs

TUESDAY, June 11 (HealthDay News) -- Compared to seniors with diabetes treated through Veterans Affairs (VA), Medicare beneficiaries with diabetes use two to three times more brand-name drugs, driving up costs substantially, according to research published online June 11 in the Annals of Internal Medicine.

Walid F. Gellad, MD, MPH, from the Veterans Affairs Pittsburgh Healthcare System, and colleagues retrospectively analyzed data from 1,061,095 Medicare Part D beneficiaries and 510,485 veterans aged 65 years or older with diabetes. The authors sought to identify the percentage of patients taking oral hypoglycemics, statins, and angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) who filled brand-name drug prescriptions and percentage of patients taking long-acting insulins who filled analogue prescriptions.

The researchers found that brand-name drug use in Medicare was two to three times that in the VA (oral hypoglycemics, 35.3 versus 12.7 percent; statins, 50.7 versus 18.2 percent; ACE inhibitors or ARBs, 42.5 versus 20.8 percent; and insulin analogues, 75.1 versus 27.0 percent). From the fifth to the 95th percentiles, adjusted hospital referral region (HRR)-level brand-name statin use ranged from 41.0 to 58.3 percent in Medicare and 6.2 to 38.2 percent in the VA. For each drug group there was lower brand-name drug use for the 95th-percentile HRR in the VA compared to the 5th-percentile HRR in Medicare. Medicare spending would have been $1.4 billion less in this population if brand-name drug use had matched that of the VA.

"Medicare beneficiaries with diabetes use two to three times more brand-name drugs than a comparable group within the VA, at substantial excess cost," the authors write.

Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Post-traumatic stress disorder and depressive symptoms may be reduced with intravenous ketamine, according to research published in JAMA Psychiatry.
As the practice of telecare continues to gain momentum, a group of researchers conducted a study to test how effective that course of treatment is in patients with chronic illnesses.
Among couples with an HIV-positive member, a study in the Cochrane Database of Systematic Reviews (CDSR) deemed antiretroviral therapy (ART) effective at preventing HIV transmission to the HIV-negative partner.
When a patient arrives at a hospital or other urgent care center, there are seemingly endless tests that can be undertaken to appropriately diagnose the patient. A recent study reviewed the necessity of some tests, particularly in regard to acute, nonspecific lower back pain.
Analysis of fatal cases of anaphylaxis in Canada uncovers several trends that point to a need for more effective monitoring and treatment strategies in high-risk patients.
GlaxoSmithKline's Arnuity approved for patients over the age of 12 as part of treatment options
Although ribotype 027 remains a significant cause of C. difficile infection (CDI), other strain types are gaining in prevalence, according to a study published in Antimicrobial Agents and Chemotherapy
More Reading